Subsequent FDG PET/CT showed high uptake in the SPN, revealing poorly differentiated adenocarcinoma at biopsy, but with no abnormal uptake in the para-aortic nodes.
Looking for Lepidic Component inside Invasive Adenocarcinomas Appearing as CT Solid Solitary Pulmonary Nodules (SPNs): CT Morpho-Densitometric Features and 18-FDG PET Findings.
The value of the maximum standardized uptake value (SUV<sub>max</sub>) for [<sup>18</sup>F]FAMT was significantly correlated with PD-L1 (E1L3N) expression, Glut1, and the SUV<sub>max</sub> for [<sup>18</sup>F]FDG in patients with histological results of adenocarcinoma (AC) and advanced disease.
This study reports the detection of FDG avid pelvic and para-aortic lymph nodes in patients with early stage cervical cancer with squamous carcinoma and adenocarcinoma tumor histology.
Two patient cohorts were retrospectively collected into a dataset of 341 <sup>18</sup>F-labeled 2-deoxy-2fluoro-d-glucose ([<sup>18</sup>F] FDG) PET-CT images of NSCLC tumours (125 ADC, 174 SqCC, and 42 cases with unknown subtype).
We showed that FDG uptake and STAS are significant prognostic markers in stage I NSCLC adenocarcinoma treated with surgical resection without adjuvant therapies.
The results of this prospective pilot study suggest that early changes in tumor FLT uptake may be better than FDG in predicting response of esophageal adenocarcinomas to neoadjuvant chemoradiation.
The average <sup>18</sup> F-FDG uptake per cell was assessed by incubating HT-29 adenocarcinoma tumor cells in <sup>18</sup> F-FDG containing solution and then measuring their activity with a scintillation well counter.
Solitary ground-glass opacity nodules of stage IA pulmonary adenocarcinoma: combination of 18F-FDG PET/CT and high-resolution computed tomography features to predict invasive adenocarcinoma.
18F-FDG PET/CT Metabolic Tumor Volume and Intratumoral Heterogeneity in Pancreatic Adenocarcinomas: Impact of Dual-Time Point and Segmentation Methods.
[<sup>18</sup>F]FDG and [<sup>11</sup>C]ACT PET were performed before and following irradiation (RT, 15Gy) for transgenic adenocarcinoma of mouse prostate xenografts.